Open AccessAntibacterial Use Is Associated with an Increased Risk of Hematologic and Gastrointestinal Adverse Events in Patients Treated with Gemcitabine for Stage IV Pancreatic Cancer
Author(s) -
R.W. Corty,
B.W. Langworthy,
J.P. Fine,
John B. Buse,
H.K. Sanoff,
J.L. Lund
Publication year - 2020
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/ah7v-3030
Subject(s) - gemcitabine , adverse effect , pancreatic cancer , medicine , stage (stratigraphy) , gastrointestinal cancer , gastroenterology , oncology , cancer , colorectal cancer , biology , paleontology